What differs is the second (and third) pathway each adds: CagriSema adds amylin, tirzepatide adds GIP, retatrutide adds both GIP and glucagon
Since pharmacological doses of GIPRAs have been found to exert anti-obesity and anti-inflammatory effects, it is tempting to propose that they could retard the atherosclerotic process and translate into reduction of adverse clinical outcomes
Special situations: blood work considerations Blood work during pregnancy Semaglutide is contraindicated in pregnancy and should be discontinued at least 2 months before a planned pregnancy (given its 7-day half-life, approximately 5 weeks of clearance time is recommended)
5.2 Role of aerobic, resistance, and HIIT modalities in combating sarcopenia Diverse exercise modalities yield overlapping yet distinct advantages for the aging muscle-vascular unit
Pancreatitis and Pancreatic Cancer Large clinical trials have not shown an increased risk of pancreatitis or pancreatic cancer with GLP-1 medications compared to placebo
Ipamorelin Ipamorelin works on the other pathway